US drugmaker Pfizer may apply for market release of its COVID-19 vaccine in the Philippines in 2022, the chief of the Food and Drug Administration (FDA) said Wednesday.
FDA Director General Eric Domingo said the drug regulator asked Pfizer when it will apply for a certificate of product registration (CPR) in the country which would allow the market release of its product.
Read more: https://newsinfo.inquirer.net/?p=1488057#ixzz76VFbKtSr
